Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Morphogenetic Proteins | 7 | 2010 | 24 | 1.600 |
Why?
|
| Transforming Growth Factor beta | 6 | 2010 | 67 | 1.270 |
Why?
|
| Osteogenesis, Distraction | 5 | 2010 | 20 | 1.120 |
Why?
|
| Cleft Lip | 6 | 2009 | 15 | 1.110 |
Why?
|
| Cleft Palate | 6 | 2009 | 24 | 1.100 |
Why?
|
| Face | 4 | 2020 | 29 | 0.840 |
Why?
|
| Adipose Tissue | 2 | 2017 | 365 | 0.840 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2020 | 83 | 0.800 |
Why?
|
| Collagen | 5 | 2009 | 239 | 0.770 |
Why?
|
| Craniofacial Abnormalities | 3 | 2008 | 14 | 0.720 |
Why?
|
| Mandible | 5 | 2008 | 39 | 0.690 |
Why?
|
| Reconstructive Surgical Procedures | 6 | 2017 | 202 | 0.690 |
Why?
|
| Surgical Flaps | 4 | 2017 | 78 | 0.680 |
Why?
|
| Osteogenesis | 4 | 2009 | 81 | 0.650 |
Why?
|
| Alveolar Process | 3 | 2009 | 5 | 0.600 |
Why?
|
| Parkinson Disease | 1 | 2020 | 92 | 0.600 |
Why?
|
| Bone Regeneration | 3 | 2008 | 33 | 0.570 |
Why?
|
| Gelatin Sponge, Absorbable | 3 | 2005 | 5 | 0.530 |
Why?
|
| Skin Transplantation | 2 | 2017 | 49 | 0.530 |
Why?
|
| Hand Injuries | 1 | 2017 | 26 | 0.520 |
Why?
|
| Biocompatible Materials | 4 | 2006 | 242 | 0.510 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 35 | 0.500 |
Why?
|
| Stromal Cells | 1 | 2016 | 84 | 0.490 |
Why?
|
| Recombinant Proteins | 5 | 2010 | 281 | 0.490 |
Why?
|
| Neck | 2 | 2008 | 31 | 0.470 |
Why?
|
| Lower Extremity | 1 | 2016 | 106 | 0.470 |
Why?
|
| Head | 2 | 2008 | 58 | 0.460 |
Why?
|
| Bone Morphogenetic Protein 2 | 6 | 2010 | 22 | 0.390 |
Why?
|
| Mandibular Advancement | 1 | 2010 | 2 | 0.330 |
Why?
|
| Pierre Robin Syndrome | 1 | 2010 | 9 | 0.320 |
Why?
|
| Airway Obstruction | 1 | 2010 | 33 | 0.320 |
Why?
|
| Mesoderm | 2 | 2008 | 13 | 0.320 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2020 | 183 | 0.310 |
Why?
|
| Absorbable Implants | 1 | 2009 | 27 | 0.300 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 2366 | 0.300 |
Why?
|
| Micrognathism | 1 | 2008 | 2 | 0.290 |
Why?
|
| Branchial Region | 1 | 2008 | 4 | 0.270 |
Why?
|
| Humans | 17 | 2020 | 34474 | 0.270 |
Why?
|
| Neural Crest | 2 | 2004 | 3 | 0.250 |
Why?
|
| Fibroma, Ossifying | 1 | 2006 | 2 | 0.240 |
Why?
|
| Mandibular Neoplasms | 1 | 2006 | 7 | 0.240 |
Why?
|
| Mandibular Diseases | 1 | 2005 | 1 | 0.240 |
Why?
|
| Alveoloplasty | 1 | 2005 | 3 | 0.230 |
Why?
|
| Organizers, Embryonic | 2 | 2004 | 2 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 152 | 0.210 |
Why?
|
| Male | 8 | 2020 | 20697 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 201 | 0.200 |
Why?
|
| Stem Cells | 1 | 2006 | 331 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 399 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2016 | 237 | 0.200 |
Why?
|
| Child, Preschool | 5 | 2008 | 1354 | 0.190 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 248 | 0.190 |
Why?
|
| Transients and Migrants | 1 | 2016 | 304 | 0.190 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 12 | 0.180 |
Why?
|
| Body Patterning | 1 | 2002 | 4 | 0.180 |
Why?
|
| Female | 8 | 2020 | 21490 | 0.180 |
Why?
|
| Wound Healing | 2 | 2016 | 190 | 0.170 |
Why?
|
| Infant, Newborn | 4 | 2010 | 730 | 0.170 |
Why?
|
| Nasal Cartilages | 1 | 2020 | 1 | 0.170 |
Why?
|
| Fascia | 1 | 2020 | 10 | 0.170 |
Why?
|
| Facial Muscles | 1 | 2020 | 2 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 948 | 0.160 |
Why?
|
| Aged | 4 | 2020 | 10998 | 0.140 |
Why?
|
| Middle Aged | 4 | 2020 | 12703 | 0.130 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 79 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2010 | 3618 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 118 | 0.130 |
Why?
|
| Ankle Brachial Index | 1 | 2016 | 40 | 0.120 |
Why?
|
| Angiography | 1 | 2016 | 79 | 0.120 |
Why?
|
| Transplantation, Autologous | 1 | 2016 | 104 | 0.120 |
Why?
|
| Ischemia | 1 | 2017 | 119 | 0.120 |
Why?
|
| Arteriosclerosis | 1 | 2016 | 150 | 0.120 |
Why?
|
| Child | 4 | 2008 | 2613 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 118 | 0.120 |
Why?
|
| Periosteum | 2 | 2006 | 9 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2016 | 887 | 0.110 |
Why?
|
| Infant | 3 | 2005 | 1122 | 0.100 |
Why?
|
| Animals | 4 | 2008 | 8544 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2010 | 3812 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 1386 | 0.080 |
Why?
|
| Adult | 3 | 2017 | 10015 | 0.080 |
Why?
|
| Tomography, Spiral Computed | 1 | 2009 | 21 | 0.080 |
Why?
|
| Intubation, Intratracheal | 1 | 2010 | 74 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 4150 | 0.070 |
Why?
|
| Oral Surgical Procedures | 1 | 2008 | 6 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1523 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 55 | 0.070 |
Why?
|
| Reoperation | 1 | 2008 | 265 | 0.060 |
Why?
|
| Calcium Phosphates | 1 | 2006 | 9 | 0.060 |
Why?
|
| Bone Substitutes | 1 | 2006 | 9 | 0.060 |
Why?
|
| Durapatite | 1 | 2006 | 10 | 0.060 |
Why?
|
| Masseter Muscle | 1 | 2005 | 1 | 0.060 |
Why?
|
| Temporal Muscle | 1 | 2005 | 1 | 0.060 |
Why?
|
| Osteocytes | 1 | 2005 | 4 | 0.060 |
Why?
|
| Bone Remodeling | 1 | 2005 | 10 | 0.060 |
Why?
|
| Tooth Eruption | 1 | 2005 | 2 | 0.060 |
Why?
|
| Bone Plates | 1 | 2006 | 74 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2005 | 44 | 0.060 |
Why?
|
| Drug Carriers | 1 | 2005 | 24 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2005 | 87 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2005 | 61 | 0.060 |
Why?
|
| Swine | 1 | 2005 | 230 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2010 | 849 | 0.060 |
Why?
|
| Bone Density | 1 | 2006 | 208 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2005 | 323 | 0.050 |
Why?
|
| Contracture | 1 | 2004 | 18 | 0.050 |
Why?
|
| Nose | 1 | 2004 | 12 | 0.050 |
Why?
|
| Mouth | 1 | 2004 | 24 | 0.050 |
Why?
|
| Skin, Artificial | 1 | 2004 | 34 | 0.050 |
Why?
|
| Cicatrix | 1 | 2004 | 41 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 924 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2005 | 484 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2005 | 628 | 0.050 |
Why?
|
| Time Factors | 2 | 2004 | 2352 | 0.040 |
Why?
|
| Olfactory Pathways | 1 | 2002 | 16 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2002 | 71 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 73 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1118 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2002 | 116 | 0.040 |
Why?
|
| Fetus | 1 | 2002 | 91 | 0.040 |
Why?
|
| North Carolina | 1 | 2016 | 1612 | 0.040 |
Why?
|
| Pregnancy | 1 | 2004 | 1069 | 0.040 |
Why?
|
| Adolescent | 2 | 2005 | 3799 | 0.040 |
Why?
|
| Chondroitin Sulfates | 1 | 2004 | 23 | 0.010 |
Why?
|